Bonus Content - Derek Lowe Unplugged: AI; Biosecure; FDA, Abortion & SCOTUS; and more
16 May 2024
32m
BioCentury · Business
BioCentury This Week
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Episodes
Ep. 231 - Biosecure Revised. Plus: Venture Rounds, Deals of Note
14 May 2024
25m
Bonus Content - Ysios' Karen Wagner: How Europe's Biotechs Can Rise Above the Noise
09 May 2024
31m
Ep. 230 - Bio€quity Europe 2024 Preview
09 May 2024
25m
Ep. 229 - ASGCT Preview, Accelerated Approval Plus: The Latest in Biosecure
07 May 2024
28m
Ep. 228 - Energizing Gene Therapy. Plus: AI Newco, Ono-Deciphera
30 Apr 2024
23m
Ep. 227 - Defending Accelerated Approval. Plus: Endpoint Innovation & AIM Amiss
22 Apr 2024
22m
Ep. 226 - Vertex’s Alpine Buy, Goldman’s Venture & IRA Tea Leaves
16 Apr 2024
22m
Ep. 225 - 2Q Markets Preview & AACR Takeaways
08 Apr 2024
21m
Ep. 224 - Biotech IPOs, Avalon & FDA at SCOTUS
02 Apr 2024
21m
Ep. 223 - Biosecure, Bruce Booth & Ultrarare Drugs
26 Mar 2024
28m
Ep. 222 - Crowley’s Vision for BIO, Plus: MASH & CAR Ts
18 Mar 2024
20m
Ep. 221 - China Biocontroversy, Plus: Diversity Matters
12 Mar 2024
31m
Ep. 220 - Biotech’s Financing Flurry & Distillery Spotlight
05 Mar 2024
24m
Ep. 219 - East-West Summit Preview
28 Feb 2024
25m
Ep. 218 - Bob Nelsen Insights, TL1A, Rare Diseases
27 Feb 2024
24m
Ep. 217 - Safer CAR Ts & World’s First TIL Therapy
21 Feb 2024
24m
Ep. 216 - Anti-China Biotech Policy: Biosecure & Beyond
16 Feb 2024
3m
Ep. 215 - ADCs, Psychedelics & IPOs
13 Feb 2024
24m
Ep. 214 - BMS’s Patent Cliff, Congress Targets China Biotech
06 Feb 2024
29m
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.